Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015

Nguyen, Duc T.; Teeter, Larry D.; Graves, Julie; Graviss, Edward A.

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015

Published Date:

Mar 2018

Source:

Emerg Infect Dis. 24(3):534-540.

[PDF-2.00 MB]

Details:

Personal Authors:

Nguyen, Duc T. ; Teeter, Larry D. ; Graves, Julie ; Graviss, Edward A. ;

Keywords:

[+]

Pubmed ID:

29460756

Pubmed Central ID:

PMC5823348

Description:

Interferon-γ release assays (IGRAs) are the preferred diagnostic test for tuberculosis (TB) infection in at-risk populations in developed countries. However, IGRAs have high false-negative rates in patients with TB disease. Population-based studies assessing the factors associated with negative IGRA results in TB patients have not been performed. Using statewide TB surveillance data of culture-confirmed TB patients in Texas, USA, during 2013-2015, we describe the patient characteristics and treatment outcomes associated with false-negative IGRA results. Among 2,854 TB patients, 1,527 (53.5%) had an IGRA result; 97.4% (1,487/1,527) of those had a positive (87.7%) or negative (12.3%) result. Older age, HIV co-infection, non-Hispanic white race/ethnicity, and being tested with T-SPOT.TB were associated with negative IGRA results. TB patients with negative IGRA results had a higher mortality, potentially due to delayed treatment. Healthcare providers should consider these risk factors when making decisions for patients with suspected TB and negative IGRA results and potentially provide treatment.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	17-1633-F1.gif	image/gif
	17-1633-F1.jpg	image/jpeg
	17-1633-F2.gif	image/gif
	17-1633-F2.jpg	image/jpeg
	17-1633-Techapp-s1.pdf	application/pdf
	17-1633.nxml	text/xml

No Related Documents.

You May Also Like:

Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection -- United States, 2010

Personal Author:

Castro, Kenneth G.; Goldberg, Stefan; Jereb, John A.; LoBue, Philip; Mazurek, Gerald H.; Vernon, Andrew;

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.. Centers for Disease Control and Prevention (U.S.). HIV Medicine Association. Infectious Diseases Society of America. National Institutes of Health (U.S.).

Published:

June 25, 2010

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 59, no. RR-5

Description:

"This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections (OIs) in HIV-infected adults (i.e., persons aged [more than or equal to] 18 years) and adolescents (i.e., persons aged ...

Status:

current

File Type:

[PDF - 501.08 KB]
Evaluation of QuantiFERON-TB Gold In-Tube and Tuberculin Skin Tests Among Immigrant Children Being Screened for Latent Tuberculosis Infection

Personal Author:

Howley, Meredith M.; Painter, John A.; Katz, Dolores J.; Graviss, Edward A.; Reves, Randall; Beavers, Suzanne F.; Garrett, Denise O.;

Published:

Jan 2015

Source:

Pediatr Infect Dis J. 34(1):35-39

Description:

Background : Centers for Disease Control and Prevention requirements for pre-immigration tuberculosis (TB) screening of children 2- to 14-years old permit a tuberculin skin test (TST) or an interferon-gamma release assay (IGRA). Few data are availabl...

File Type:

[PDF - 472.73 KB]
Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence

Personal Author:

Lange, Christoph; Mandalakas, Anna M.; Kalsdorf, Barbara; Denkinger, Claudia M.; Sester, Martina;

Published:

Jan 04 2016

Source:

Pathog Immun. 1(2):308-329

Description:

Despite global efforts to control tuberculosis (TB) the estimated number of people who developed TB worldwide increased to an all-time record of more than 10 million in 2015. The goal of the World Health Organization (WHO) to reduce the global incide...

File Type:

[PDF - 368.19 KB]
Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens

Personal Author:

Kellar, Kathryn L.; Gehrke, Jennifer; Weis, Stephen E.; Mahmutovic-Mayhew, Aida; Davila, Blachy; Zajdowicz, Margan J.; Scarborough, Robin; LoBue, Philip A.; Lardizabal, Alfred A.; Daley, Charles L.; Reves, Randall R.; Bernardo, John; Campbell, Brandon H.; Whitworth, William C.; Mazurek, Gerald H.;

Published:

Nov 21 2011

Source:

PLoS One. 2011; 6(11).

Description:

Background : Mycobacterium tuberculosis (Mtb) infection may cause overt disease or remain latent. Interferon gamma release assays (IGRAs) detect Mtb infection, both latent infection and infection manifesting as overt disease, by measuring whole-blood...

File Type:

[PDF - 772.08 KB]
Diagnosis of Tuberculosis by an Enzyme-Linked Immunospot Assay for Interferon-γ

Personal Author:

Wang, Jann-Yuan; Chou, Chien-Hong; Lee, Li-Na; Hsu, Hsiao-Leng; Jan, I-Shiow; Hsueh, Po-Ren; Yang, Pan-Chyr; Luh, Kwen-Tay;

Published:

Apr 2007

Source:

Emerg Infect Dis. 13(4):553-558.

Description:

We evaluated an enzyme-linked immunospot assay for interferon-gamma (T SPOT-TB) for rapid diagnosis of active tuberculosis (TB) in a disease-endemic area. From January to June 2005, patients whose clinical symptoms and radiographic findings were comp...

File Type:

[PDF - 194.35 KB]